The current research investigates the correlation of miR‐100 and miR‐101 with the mTOR/AKT/PI3K pathway to lay the groundwork for future studies of AML pathways, with the hope of enhancing our understanding of AML pathogenesis. The gene discussed is AKT1; the disease is acute myeloid leukemia.